Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bingxin Gu

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|September 23, 2025
Preclinical and first-in-human evaluation of novel androgen receptor-targeted PET imaging in prostate cancerShuyi Lin, Xiangwei Wang, Fangning Wan, et al.
Annals of Nuclear Medicine|February 26, 2018
The feasibility of <sup>18</sup>F-FES and <sup>18</sup>F-FDG microPET/CT for early monitoring the effect of fulvestrant on sensitizing docetaxel by downregulating ERα in ERα+ breast cancerShuai Liu, Bingxin Gu, Jianping Zhang, et al.
Frontiers in Oncology|May 2, 2022
Prognostic Value of Heterogeneity Index Derived from Baseline <sup>18</sup>F-FDG PET/CT in Mantle Cell LymphomaFei Liu, Bingxin Gu, Nan Li, et al.
Molecular Pharmaceutics|January 28, 2025
Preclinical and First-In-Human Imaging of Novel [<sup>18</sup>F]F-FAPI-FUSCC-07 Tracer: Comparative Prospective Study with [<sup>18</sup>F]F-FAPI-42 and [<sup>18</sup>F]F-FAPI-74Linjie Bian, Xinyu Liu, Xiao Wang, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|October 15, 2016
High specific activity is not optimal: <sup>18</sup> F-fluoroestradio positron emission tomography-computed tomography results in a breast cancer xenograftZhongyi Yang, Huiyu Yuan, Xiaoping Xu, et al.
Journal of Materials Chemistry. B|July 4, 2025
Multifunctional nanodrug-enabled mild photothermal therapy for enhanced immunotherapy in triple-negative breast cancerXinyue Du, Ying Zhang, Bingxin Gu, et al.
Frontiers in Oncology|May 31, 2021
A Novel Validated Recurrence Stratification System Based on <sup>18</sup>F-FDG PET/CT Radiomics to Guide Surveillance After Resection of Pancreatic CancerMiaoyan Wei, Bingxin Gu, Shaoli Song, et al.
Bioactive Materials|September 12, 2022
<i>In situ</i> forming oxygen/ROS-responsive niche-like hydrogel enabling gelation-triggered chemotherapy and inhibition of metastasisShi-Xiong Chen, Ji Zhang, Fengfeng Xue, et al.
Oncotarget|March 5, 2016
The preclinical study of predicting radiosensitivity in human nasopharyngeal carcinoma xenografts by 18F-ML-10 animal- PET/CT imagingXiao Bao, Zhongyi Yang, Siyang Wang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 2021
The Added Value of <sup>68</sup>Ga-FAPI PET/CT in Patients with Head and Neck Cancer of Unknown Primary with <sup>18</sup>F-FDG-Negative FindingsBingxin Gu, Xiaoping Xu, Ji Zhang, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
European Journal of Nuclear Medicine and Molecular Imaging|September 23, 2025
Preclinical and first-in-human evaluation of novel androgen receptor-targeted PET imaging in prostate cancerShuyi Lin, Xiangwei Wang, Fangning Wan, et al.
Annals of Nuclear Medicine|February 26, 2018
The feasibility of <sup>18</sup>F-FES and <sup>18</sup>F-FDG microPET/CT for early monitoring the effect of fulvestrant on sensitizing docetaxel by downregulating ERα in ERα+ breast cancerShuai Liu, Bingxin Gu, Jianping Zhang, et al.
Frontiers in Oncology|May 2, 2022
Prognostic Value of Heterogeneity Index Derived from Baseline <sup>18</sup>F-FDG PET/CT in Mantle Cell LymphomaFei Liu, Bingxin Gu, Nan Li, et al.
Molecular Pharmaceutics|January 28, 2025
Preclinical and First-In-Human Imaging of Novel [<sup>18</sup>F]F-FAPI-FUSCC-07 Tracer: Comparative Prospective Study with [<sup>18</sup>F]F-FAPI-42 and [<sup>18</sup>F]F-FAPI-74Linjie Bian, Xinyu Liu, Xiao Wang, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|October 15, 2016
High specific activity is not optimal: <sup>18</sup> F-fluoroestradio positron emission tomography-computed tomography results in a breast cancer xenograftZhongyi Yang, Huiyu Yuan, Xiaoping Xu, et al.
Journal of Materials Chemistry. B|July 4, 2025
Multifunctional nanodrug-enabled mild photothermal therapy for enhanced immunotherapy in triple-negative breast cancerXinyue Du, Ying Zhang, Bingxin Gu, et al.
Frontiers in Oncology|May 31, 2021
A Novel Validated Recurrence Stratification System Based on <sup>18</sup>F-FDG PET/CT Radiomics to Guide Surveillance After Resection of Pancreatic CancerMiaoyan Wei, Bingxin Gu, Shaoli Song, et al.
Bioactive Materials|September 12, 2022
<i>In situ</i> forming oxygen/ROS-responsive niche-like hydrogel enabling gelation-triggered chemotherapy and inhibition of metastasisShi-Xiong Chen, Ji Zhang, Fengfeng Xue, et al.
Oncotarget|March 5, 2016
The preclinical study of predicting radiosensitivity in human nasopharyngeal carcinoma xenografts by 18F-ML-10 animal- PET/CT imagingXiao Bao, Zhongyi Yang, Siyang Wang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 2021
The Added Value of <sup>68</sup>Ga-FAPI PET/CT in Patients with Head and Neck Cancer of Unknown Primary with <sup>18</sup>F-FDG-Negative FindingsBingxin Gu, Xiaoping Xu, Ji Zhang, et al.
Pageof 5